Real world data and data science in medical research: present and future

Abstract

Real world data (RWD) are generating greater interest in recent times despite being not new. There are various purposes of the RWD analytics in medical research as follows: effectiveness and safety of medical treatment, epidemiology such as incidence and prevalence of disease, burden of disease, quality of life and activity of daily living, medical costs, etc. The RWD research in medicine is a mixture of digital transformation, statistics or data science, public health, and regulatory science. Most of the articles describing the RWD or real-world evidence (RWE) in medical research cover only a portion of these specializations, which might lead to an incomplete understanding of the RWD. This article summarizes the overview and challenges of the RWD analysis in medical fields from methodological perspectives. As the first step for the RWD analysis, data source of the RWD should be comprehended. The progress of the RWD is closely related to the digitization, especially of medical administrative data and medical records. Second, the selection of appropriate statistical and epidemiological methods is highly critical for an RWD analysis than those for randomized clinical trials. This is because it contains greater varieties of bias, which should be controlled by balancing the underlying risk between treatment groups. Last, the future of the RWD is discussed in terms of overcoming limited data by proxy confounders, using unstructured text data, linking of multiple databases, using the RWD or RWE for a regulatory purpose, and evaluating values and new aspects in medical research brought by the RWD.

Use of Real-World Evidence in Regulatory Decisions for Traditional Chinese Medicine: Current Status and Future Directions

“…Compared to RCTs, RWE in TCM research is often considered lower in the evidence hierarchy [ 60 , 61 ]. This can lead to challenges in gaining acceptance and recognition from regulatory bodies, healthcare professionals, and researchers.…”

Strategies to Address Current Challenges in Real-World Evidence Generation in Japan

“…Furthermore, inappropriate analytical methodologies may lead to biased evidence generation, undermining the credibility of RWE. Although PMDA offers expertise to pharmaceutical companies, there is no formal process in place to systematically utilize this support, and the choice of inappropriate study design and analytical methods may negatively influence study results [ 12 , 13 ]. Other challenges that could limit the interpretation of results include sensitivity analysis, analytical models, measurement of validity, and confounding.…”

INSIGHT: A Tool for Fit-for-Purpose Evaluation and Quality Assessment of Observational Data Sources for Real World Evidence on Medicine and Vaccine Safety

“…3 Comprehensive analyses of these approaches have been published. 4 The lack of knowledge regarding the use and safety of medicines and vaccines during pregnancy and lactation is widely recognized. Studies indicate that 70-90% of women are exposed to a prescription medicine during pregnancy.…”